News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel.

UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel. 27/04/2016World’s largest global wealth manager concludes fundraising for innovative impact investing fund aimed at developing cancer treatmentsUBS Wealth Management has raised a record $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments.Investments will be made in early stage oncology to accelerate the development of new cures. Ca


2. BTG plc Acquires Galil Medical, a Leader in Cryoablation

BTG plc Acquires Galil Medical, a Leader in Cryoablation 06/05/2016Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation marketGalil Medical is a leader in cryoablation of kidney cancer with significant pipeline opportunities including lung cancerBTG plc (LSE: BTG), the specialist healthcare company, today announces that it has entered into an agreement to acquire Galil Medical, a leading provider of cryoablation products


3. Oxford BioMedica Presents Ground-breaking Evidence of Long-term Durati

Oxford BioMedica Presents Ground-breaking Evidence of Long-term Duration of Therapeutic Expression in Patients from its Proprietary LentiVector Gene Delivery Platform06/05/2016Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy company, today announces that new data has been presented from two clinical studies indicating ground-breaking long-term four-year sustained and, in one of the studies, dose-dependent gene expressio


4. AMSBIO Introduces New Reagents for Organoid Growth and Harvesting

AMSBIO Introduces New Reagents for Organoid Growth and Harvesting 05/05/2016Abingdon, UK – AMSBIO has introduced two new products to assist the increasing number of scientists adopting organoid culture as a physiologically relevant model for organ development.These new tools build upon the widespread use of AMSBIO’s BME2 ‘organoid matrix’ by leading research groups worldwide. BME 2 is the extracellular matrix of choice for growing and supporting organoid cultures tha


5. BTG plc Acquires Galil Medical, a Leader in Cryoablation

BTG plc Acquires Galil Medical, a Leader in Cryoablation06/05/2016Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation market. Galil Medical is a leader in cryoablation of kidney cancer with significant pipeline opportunities including lung cancerLondon, UK, 06 May 2016: BTG plc, the specialist healthcare company, today announces that it has entered into an agreement to acquire Galil Medical, a leading provider of cryoablatio



Page 11 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2019